abstract |
PHARMACEUTICAL COMPOSITION, DIAGNOSTIC METHOD OR DISEASE MONITORING, USES OF AGENT, ANTIBODY, AND CYTOLYTIC T CELLS OR WHICH RELEASE CYTOKIN, AGENT, ANTIBODY, CONJUGATE AND KIT. The present invention relates to genetic products, the expression of which is associated with cancerous diseases. The invention also relates to therapy and diagnosis of diseases in which genetic products are expressed or abnormally expressed, in particular carcinogenic diseases. |